Top Tweets for #bladderpath
🧩 Bladder riddle
Inspired by the previous post…
Here is another spindle cell neoplasm. 🤔
Bland-looking spindle cells with eosinophilic cytoplasm, oval nuclei, and small round nucleoli.
What would be your diagnosis?
#DxMindMap #GUPath #BladderPath #PathTwitter @JHUpath
Sarcomatoid carcinoma composed of malignant spindle cells reminiscent of IMT, with a small focus of chondrosarcomatous differentiation.
🧩 Bladder riddle
When urothelial carcinoma decides to go wild before conventional invasion pattern (Desmoplasia ; Retraction artifact ; Complex architecture ;Paradoxical differentiation)
What would be your diagnosis?
#DxMindMap #GUPath #BladderPath #PathTwitter @JHUpath
#PathQuiz 🔬
A) Urothelial Papilloma
B) Papillary Urothelial Neoplasm of Low Malignant Potential
C) Non-invasive Papillary Urothelial Carcinoma, High-Grade
D) Non-invasive Papillary Urothelial Carcinoma, Low-Grade
#Pathology #GUPath #BladderPath
Randomized comparison of MRI versus transurethral resection for staging new #BladderCancers: Final survival analysis from the #BladderPath trial. Presentation by James Catto, PhD @sheffielduni. #EAU26 written coverage by @zklaassen_md @GACancerCenter > https://t.co/WmCtlVWHZR @Uroweb
Redefining the #MIBC Pathway: A multicenter study examining the real world potential impact of implementing #BladderPath. Presentation by Tom Malik. Presentation by @zklaassen_md > https://t.co/vTX3ruRnsL @NorthBristolNHS @Uroweb
Analysis of MRI use in the diagnostic pathway for #BladderCancer. @Prof_Nick_James @ICR_London joins @UroDocAsh @MDAndersonNews to discuss the final #BladderPath trial survival analyses, demonstrating mpMRI introduced upstream of TURBT significantly improves bladder cancer-specific survival with a statistically significant hazard ratio driven entirely by muscle-invasive disease outcomes. #WatchNow on UroToday > https://t.co/3deEcKOwVz #ESMO25
Analysis of MRI use in the diagnostic pathway for #BladderCancer. @Prof_Nick_James @ICR_London joins @UroDocAsh @MDAndersonNews to discuss the final #BladderPath trial survival analyses, demonstrating mpMRI introduced upstream of TURBT significantly improves bladder cancer-specific survival with a statistically significant hazard ratio driven entirely by muscle-invasive disease outcomes. #WatchNow on UroToday > https://t.co/3deEcKOwVz #ESMO25
Analysis of MRI use in the diagnostic pathway for #BladderCancer. @Prof_Nick_James @ICR_London joins @UroDocAsh @MDAndersonNews to discuss the final #BladderPath trial survival analyses, demonstrating mpMRI introduced upstream of TURBT significantly improves bladder cancer-specific survival with a statistically significant hazard ratio driven entirely by muscle-invasive disease outcomes. #WatchNow on UroToday > https://t.co/3deEcKOwVz #ESMO25
Analysis of MRI use in the diagnostic pathway for #BladderCancer. @Prof_Nick_James @ICR_London joins @UroDocAsh @MDAndersonNews to discuss the final #BladderPath trial survival analyses, demonstrating mpMRI introduced upstream of TURBT significantly improves bladder cancer-specific survival with a statistically significant hazard ratio driven entirely by muscle-invasive disease outcomes. #WatchNow on UroToday > https://t.co/3deEcKOwVz #ESMO25
At #ESMO25, Nicholas James, MD, PhD, discusses results from the #BladderPath trial comparing TURBT-based staging with an MRI-guided pathway for suspected muscle-invasive bladder cancer. Learn more: https://t.co/lojc3mdzuR
#medtwitter #onctwitter
Analysis of MRI use in the diagnostic pathway for #BladderCancer. @Prof_Nick_James @ICR_London joins @UroDocAsh @MDAndersonNews to discuss the final #BladderPath trial survival analyses, demonstrating mpMRI introduced upstream of TURBT significantly improves bladder cancer-specific survival with a statistically significant hazard ratio driven entirely by muscle-invasive disease outcomes. #WatchNow on UroToday > https://t.co/3deEcKOwVz #ESMO25
Randomized comparison of upfront MRI vs transurethral resection for staging new bladder cancers: Final survival analysis from the #BladderPath trial. Presentation by @Prof_Nick_James @ICR_London. #ESMO25 written coverage by @zklaassen_md @GACancerCenter > https://t.co/mKjCJh5xqo @myESMO @UroDocAsh
Analysis of MRI use in the diagnostic pathway for #BladderCancer. @Prof_Nick_James @ICR_London joins @UroDocAsh @MDAndersonNews to discuss the final #BladderPath trial survival analyses, demonstrating mpMRI introduced upstream of TURBT significantly improves bladder cancer-specific survival with a statistically significant hazard ratio driven entirely by muscle-invasive disease outcomes. #WatchNow on UroToday > https://t.co/3deEcKOwVz #ESMO25
Example of a ‘shoulder’ lesion in a high grade non invasive UC.
Don’t overcall this as CIS. The edge of the papillary lesion creeps into flat urothelium. #bladderpath #gupath. @MichelleDunno17 speaks well on this subject!
We have just published the #BladderPath #ClinicalTrial results have just been published in @JCO_ASCO https://t.co/f6VGEtEjuu
Thank you to all the participants and research teams for their contributions and support
@Prof_Nick_James @Actionbladderca @NIHRresearch
Our editorial on the #BladderPath study: Could MRI-first staging streamline MIBC treatment? Skipping TURBT may reduce delays—especially for those needing palliative care or radiotherapy. @JCO_ASCO @AndreaNecchi @JimCatto @Prof_Nick_James #OncSurgery #BladderCancer
https://t.co/65itS0AqHB
New insights from the #BladderPath trial: Using mpMRI for staging MIBC cut the time to treatment nearly in half (53 vs. 98 days). Fewer metastases (10% vs. 26%) and lower disease-related mortality (30% vs. 70%) too. @JCO_ASCO @Prof_Nick_James
MRI should be a routine for daily management of MIBC - @AndreaNecchi
@ICR_London @Prof_Nick_James
https://t.co/AT0feJcvA8
#BladderCancer #BladderPath #Cancer #ICR #JCO #Oncology #MIBC #MRI #OncoDaily #ProstateCancer
Last Seen Hashtags on Sotwe
AjengSekarKirana
Seen from Colombia
cheatingkink
Seen from Spain
freeporn
Seen from United Kingdom
NolaChampions
Seen from South Africa
nolimit() +filter:native_video since:2026-05-08
Seen from Colombia
阿波崎城跡
Seen from Brazil
終末のアーチャー
Seen from United Arab Emirates
arabfeet
Seen from Israel
fartinmouth
xlii()*************
Seen from Turkey
Most Popular Users
Elon Musk 
@elonmusk
240.1M followers
Barack Obama
@barackobama
119.3M followers
Donald J. Trump
@realdonaldtrump
111.6M followers
Cristiano Ronaldo
@cristiano
108.7M followers
Narendra Modi
@narendramodi
106.9M followers
Rihanna
@rihanna
97.2M followers
NASA
@nasa
92.1M followers
Justin Bieber
@justinbieber
90.5M followers
KATY PERRY
@katyperry
86.7M followers
Taylor Swift
@taylorswift13
80.5M followers
Lady Gaga
@ladygaga
72.1M followers
Kim Kardashian
@kimkardashian
69.3M followers
YouTube
@youtube
68.6M followers
Virat Kohli
@imvkohli
68.4M followers
Bill Gates
@billgates
63.3M followers
The Ellen Show
@theellenshow
62.5M followers
CNN
@cnn
61.9M followers
Neymar Jr
@neymarjr
60.9M followers
X
@x
60.9M followers
CNN Breaking News
@cnnbrk
59.9M followers